New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. One of neurologist Anelyssa D’Abreu’s least ...

I understand that there is treatment for the beginning stages of Alzheimer's disease that can stave off serious decline.

A bill introduced in the Nebraska Legislature would require insurers to cover FDA-approved Alzheimer's drugs for the 35,000+ residents impacted. Nebraska would become the second state to do so.

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics ...

For decades, scientists have targeted the sticky protein clumps that amass in Alzheimer's brains as a potential way of treating the disease, but they may have been off the mark. A new study shows that ...

A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research Institute. The research finds that beta amyloid—a ...

This November is Alzheimer’s Awareness Month, when patients and physicians raise awareness and show support for the millions of people affected by Alzheimer’s Disease. More than 7 million Americans ...

A brain scan of a person with Alzheimer’s disease. (Image courtesy of the Keck School of Medicine at USC) In my role at Alzheimer’s San Diego, where I work directly with clients and assess their needs ...

A study of 470,000 people reveals that the APOE gene could be behind 90% of Alzheimer's cases in the world today.

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...